SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 129 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $174,000 | -44.9% | 17,000 | -29.8% | 0.00% | -40.0% |
Q2 2016 | $316,000 | +41.1% | 24,200 | -0.4% | 0.01% | +66.7% |
Q4 2015 | $224,000 | +31.0% | 24,300 | -1.6% | 0.00% | 0.0% |
Q3 2015 | $171,000 | -24.7% | 24,700 | +6.9% | 0.00% | 0.0% |
Q2 2015 | $227,000 | +4.6% | 23,100 | -5.7% | 0.00% | 0.0% |
Q1 2015 | $217,000 | – | 24,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |